| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |